Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma

Kumiko Shono, Tatsurou Tajiri, Yoshimitsu Fujii, Sachiyo Suita

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: In patients with neuroblastoma (NB), minimal disease (MD) in bone marrow (BM) and peripheral blood (PB) is thought to play an important role in metastasis. The current study was designed to evaluate the clinical implications of the detection of MD in NB at the initial diagnosis. Methods: Expression of the neuroendocrine protein gene product 9.5 (PGP9.5) and tyrosine hydroxylase (TH) mRNA in BM and PB obtained from 18 patients with NB was investigated by reverse transcriptase-polymerase chain reaction (RT-PCR). Results: MD was detected in the BM obtained from 4 of 14 localized NB patients and also in the PB from 2. However, it was found also in both the BM and PB obtained from all 4 patients with metastatic NB. Two of the 4 MD-positive patients with localized NB had metastatic recurrence after a complete tumor excision. They also had unfavorable biological prognostic factors compared with the other 2 who did not have recurrent disease. Conclusion: MD detected by RT-PCR in the BM and the PB of patients with NB thus suggests a risk for metastatic disease, which in association with other unfavorable biological features may indicate a poor prognosis. (C) 2000 by W.B. Saunders Company.

Original languageEnglish
Pages (from-to)1415-1420
Number of pages6
JournalJournal of Pediatric Surgery
Volume35
Issue number10
DOIs
Publication statusPublished - 2000

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Surgery

Fingerprint

Dive into the research topics of 'Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma'. Together they form a unique fingerprint.

Cite this